Core Laboratories Net Worth
Core Laboratories Net Worth Breakdown | CLB |
Core Laboratories Net Worth Analysis
Core Laboratories' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Core Laboratories' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Core Laboratories' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Core Laboratories' net worth analysis. One common approach is to calculate Core Laboratories' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Core Laboratories' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Core Laboratories' net worth. This approach calculates the present value of Core Laboratories' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Core Laboratories' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Core Laboratories' net worth. This involves comparing Core Laboratories' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Core Laboratories' net worth relative to its peers.
Enterprise Value |
|
To determine if Core Laboratories is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Core Laboratories' net worth research are outlined below:
| Core Laboratories generated a negative expected return over the last 90 days | |
| Core Laboratories has high historical volatility and very poor performance | |
| Over 99.0% of the company shares are held by institutions such as insurance companies | |
| On 27th of May 2025 Core Laboratories paid $ 0.01 per share dividend to its current shareholders | |
| Latest headline from thelincolnianonline.com: Q3 EPS Estimate for Core Laboratories Decreased by Analyst |
Core Laboratories Quarterly Good Will |
|
Core Laboratories uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Core Laboratories NV. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Core Laboratories' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 31st of January 2024 Upcoming Quarterly Report | View | |
| 24th of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 31st of January 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Core Laboratories' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Core Laboratories is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Core Laboratories NV backward and forwards among themselves. Core Laboratories' institutional investor refers to the entity that pools money to purchase Core Laboratories' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Fred Alger Management, Llc | 2025-03-31 | 736.9 K | Btim Corp | 2025-03-31 | 610.9 K | Morgan Stanley - Brokerage Accounts | 2025-03-31 | 589.6 K | Northern Trust Corp | 2024-12-31 | 577.8 K | Charles Schwab Investment Management Inc | 2025-03-31 | 498 K | Gendell Jeffrey L | 2025-03-31 | 457 K | Bank Of New York Mellon Corp | 2025-03-31 | 410.4 K | Hotchkis & Wiley Capital Management Llc | 2025-03-31 | 400.8 K | Van Eck Associates Corporation | 2025-03-31 | 395.1 K | Ariel Investments, Llc | 2025-03-31 | 10.3 M | Blackrock Inc | 2025-03-31 | 7.5 M |
Follow Core Laboratories' market capitalization trends
The company currently falls under 'Small-Cap' category with a total capitalization of 517.12 M.Market Cap |
|
Project Core Laboratories' profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.06 | 0.06 | |
| Return On Capital Employed | 0.12 | 0.21 | |
| Return On Assets | 0.05 | 0.10 | |
| Return On Equity | 0.12 | 0.12 |
When accessing Core Laboratories' net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Core Laboratories' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Core Laboratories' profitability and make more informed investment decisions.
Please note, the presentation of Core Laboratories' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Core Laboratories' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Core Laboratories' management manipulating its earnings.
Evaluate Core Laboratories' management efficiency
Core Laboratories has Return on Asset of 0.053 % which means that on every $100 spent on assets, it made $0.053 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1157 %, implying that it generated $0.1157 on every 100 dollars invested. Core Laboratories' management efficiency ratios could be used to measure how well Core Laboratories manages its routine affairs as well as how well it operates its assets and liabilities. At present, Core Laboratories' Return On Capital Employed is projected to slightly decrease based on the last few years of reporting. The current year's Return On Assets is expected to grow to 0.1, whereas Return On Tangible Assets are forecasted to decline to 0.06. At present, Core Laboratories' Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 25.6 M, whereas Total Assets are forecasted to decline to about 553.5 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 5.50 | 5.77 | |
| Tangible Book Value Per Share | 3.24 | 3.40 | |
| Enterprise Value Over EBITDA | 13.28 | 12.56 | |
| Price Book Value Ratio | 3.22 | 6.30 | |
| Enterprise Value Multiple | 13.28 | 12.56 | |
| Price Fair Value | 3.22 | 6.30 | |
| Enterprise Value | 875.5 M | 831.7 M |
The decision-making processes within Core Laboratories are key to its success in a competitive market. By evaluating these processes, we assess the stock's potential for future gains.
Enterprise Value Revenue 1.2837 | Revenue | Quarterly Revenue Growth (0.05) | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Core Laboratories insiders, such as employees or executives, is commonly permitted as long as it does not rely on Core Laboratories' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Core Laboratories insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Core Laboratories Corporate Filings
8K | 27th of May 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 19th of May 2025 Other Reports | ViewVerify | |
| 15th of May 2025 Other Reports | ViewVerify | |
F4 | 5th of May 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Core Laboratories Earnings per Share Projection vs Actual
Core Laboratories Corporate Management
| Gwendolyn MBA | Senior Relations | Profile | |
| J Dumas | Vice President Business Development | Profile | |
| Martha Carnes | Presiding Non-Executive Lead Independent Member of the Supervisory Board | Profile | |
| Monique Eeuwijk | Non-Executive Independent Member of the Supervisory Board | Profile | |
| Jacobus Schouten | Managing Director | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Laboratories NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Oil & Gas Equipment & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.896 | Dividend Share 0.04 | Earnings Share 0.59 | Revenue Per Share | Quarterly Revenue Growth (0.05) |
The market value of Core Laboratories is measured differently than its book value, which is the value of Core that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Core Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.